{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:40:07Z","timestamp":1787773207977,"version":"build-2784847793"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>We report the first case of an acute ST-segment elevation myocardial infarction (AMI) induced by docetaxel in a patient with triple-negative breast cancer (BC). Coronary angiography showed severe occlusions in multiple coronary arteries, and timely PCI surgery was successfully performed, saving the patient's life. Docetaxel is a commonly used taxane chemotherapy drug for treating breast cancer, which can cause numerous adverse drug reactions in cancer treatment. However, compared with paclitaxel, reports of docetaxel-induced cardiotoxicity are fewer and generally milder, and acute myocardial infarction induced by docetaxel is extremely rare and potentially fatal when it occurs. Due to this severe adverse drug reaction, the subsequent docetaxel chemotherapy regimen was discontinued. In addition, we review this case alongside 12 published case reports and conduct a comprehensive analysis of 94 reported instances of myocardial infarction associated with taxane use from the FDA Adverse Event Reporting System (FAERS) database, evaluating their clinical relevance and key characteristics. In this case, we highly suspect that docetaxel directly caused the acute myocardial infarction, and propose that the mechanism may involve coronary vasospasm, endothelial dysfunction, or prothrombotic effects, although the exact pathway remains unclear. This study, through the rare case of a breast cancer patient who experienced acute myocardial infarction after docetaxel chemotherapy, demonstrates timely and proper cardiac management in a patient assessed as low-risk for cardiotoxicity with no relevant cardiovascular factors. Furthermore, through literature review combined with the FAERS database, we further discuss possible mechanisms, influencing factors, and predictive methods to provide clinical reference and warnings.<\/jats:p>","DOI":"10.3389\/fcvm.2026.1791074","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:54:47Z","timestamp":1780030487000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A patient with triple-negative breast cancer developed acute myocardial infarction after docetaxel chemotherapy: case report and literature review"],"prefix":"10.3389","volume":"13","author":[{"given":"Fangqin","family":"Tong","sequence":"first","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Huang","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingzhou","family":"Xiang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Oncology, Wuhan Asia General Hospital","place":["Wuhan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"B1","year":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1177\/1078155217714860","article-title":"Docetaxel-induced cardiac-respiratory arrest in a patient with chronic atrial fibrillation","volume":"24","author":"Huq","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.5306\/wjco.v15.i10.1309","article-title":"Acute severe hypokalemia caused by treatment of tongue squamous cell carcinoma with docetaxel and cisplatin:a case report","volume":"15","author":"Jiang","year":"2024","journal-title":"World J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/annonc\/mdf084","article-title":"Gastrointestinal toxicity associated with weekly docetaxel treatment","volume":"13","author":"Stemmler","year":"2002","journal-title":"Ann Oncol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1093\/jnci\/djs317","article-title":"Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment:a retrospective cohort study","volume":"104","author":"Bowles","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1200\/JCO.2001.19.10.2746","article-title":"Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients","volume":"19","author":"Meinardi","year":"2001","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0960-9776(08)70005-5","article-title":"European Oncologists\u2019preferences for the management of breast cancer:case presentations and expert commentary","volume":"17","author":"Anderssona","year":"2008","journal-title":"Breast"},{"key":"B8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1200\/JCO.1985.3.6.818","article-title":"A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer","volume":"3","author":"Jain","year":"1985","journal-title":"J Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/clc.4960210911","article-title":"Comparison of epirubicin and doxorubicin cardiotoxicity induced by low doses:evolution of the diastolic and systolic parameters studied by radionuclide angiography","volume":"21","author":"Cottin","year":"1998","journal-title":"Clin Cardiol"},{"key":"B10","first-page":"686","article-title":"Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7","volume":"29","author":"Innocenti","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"B11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/0973-1482.103530","article-title":"Acute non-ST elevation myocardial infarction following paclitaxel administration for ovarian carcinoma:a case report and review of literature","volume":"8","author":"Shah","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/s0936-6555(05)80452-2","article-title":"Acute myocardial infarction following paclitaxel administration for ovarian carcinoma","volume":"9","author":"Laher","year":"1997","journal-title":"Clin Oncol(R Coll Radiol)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1177\/106002809603001008","article-title":"Fatal myocardial infarction potentially induced by paclitaxel","volume":"30","author":"Hekmat","year":"1996","journal-title":"Ann Pharmacother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40959-022-00148-9","article-title":"Acute ST-segment elevations following paclitaxel administration for uterine cervical cancer:a case report and literature review","volume":"8","author":"Higami","year":"2022","journal-title":"Cardiooncology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4070\/kcj.2009.39.3.124","article-title":"Coronary artery thrombosis associated with paclitaxel in advanced ovarian cancer","volume":"39","author":"Park","year":"2009","journal-title":"Korean Circ J"},{"key":"B16","first-page":"498","article-title":"Symptoms and signs of an acute myocardial ischemia caused by chemotherapy with paclitaxel (taxol) in a patient with metastatic ovarian carcinoma","volume":"10","author":"Schrader","year":"2005","journal-title":"Eur J Med Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"E94","DOI":"10.1002\/clc.20291","article-title":"Paclitaxel-induced ST-segment elevations","volume":"32","author":"Gemici","year":"2009","journal-title":"Clin Cardiol"},{"key":"B18","first-page":"342","article-title":"Paclitaxel-induced myocardial infarction in a case of carcinoma ovary","volume":"57","author":"Londhey","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"B19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.14740\/cr325w","article-title":"Acute myocardial infarction in patient with triple negative breast cancer after paclitaxel infusion:a case report","volume":"5","author":"Esber","year":"2014","journal-title":"Cardiol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"XD01","DOI":"10.7860\/JCDR\/2016\/21396.8614","article-title":"Paclitaxel induced acute ST elevation myocardial infarction:a rare case report","volume":"10","author":"Rawal","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12872-024-03814-1","article-title":"Paclitaxel-induced acute myocardial infarction:a case report and literature review","volume":"24","author":"Kim","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"B22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12872-021-01936-4","article-title":"Epirubicin-induced kounis syndrome","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"B23","first-page":"117","article-title":"A reassessment of cardiac toxicity associated with taxol","volume":"15","author":"Arbuck","year":"1993","journal-title":"J Natl Cancer Inst Monogr"},{"key":"B24","first-page":"77","article-title":"Kounis syndrome (allergic angina and allergic myocardial infarction)","volume-title":"Angina Pectoris: Etiology, Pathogenesis and Treatment","author":"Kounis","year":"2008"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1177\/1078155219896848","article-title":"Potential cross-reactivity of polysorbate 80 and cremophor:a case report","volume":"26","author":"Bibera","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"B26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.ejvs.2021.05.043","article-title":"Editor\u2019s choice-paclitaxel coated balloon angioplasty vs. Plain balloon angioplasty for haemodialysis arteriovenous access stenosis:a systematic review and a time to event meta-analysis of randomised controlled trials","volume":"62","author":"Han","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/polym14040658","article-title":"Paclitaxel drug delivery systems:focus on Nanocrystals\u2019Surface modifications","volume":"14","author":"Haddad","year":"2022","journal-title":"Polymers(Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ijbiomac.2019.12.145","article-title":"Chitosan-based advanced materials for docetaxel and paclitaxel delivery:recent advances and future directions in cancer theranostics","volume":"145","author":"Ashrafizadeh","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1016\/j.jcin.2015.03.034","article-title":"Development of late stent malapposition after paclitaxel-coated balloon angioplasty for in-stent neoatherosclerosis","volume":"8","author":"Yumoto","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/15385744251326259","article-title":"Suspected paclitaxel allergy following angioplasty with a drug-coated balloon","volume":"59","author":"Haffler","year":"2025","journal-title":"Vasc Endovascular Surg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"bcr2015214236","DOI":"10.1136\/bcr-2015-214236","article-title":"In the nick of time: arterial thrombosis on starting combination chemotherapy in metastatic gastric adenocarcinoma","volume":"2016","author":"Boon","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e230499","DOI":"10.1136\/bcr-2019-230499","article-title":"Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug","volume":"12","author":"Mishra","year":"2019","journal-title":"BMJ Case Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"104465","DOI":"10.1016\/j.breast.2025.104465","article-title":"Paclitaxel-related type I kounis syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario:a case report and narrative review","volume":"81","author":"Mu\u00f1oz","year":"2025","journal-title":"Breast"},{"key":"B34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ehjci\/jeaa339","article-title":"Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the working group on drug cardiotoxicity and cardioprotection, Italian society of cardiology(SIC)","volume":"22","author":"Zito","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3233\/CBM-181301","article-title":"Correlation of circulating pro-angiogenic miRNAs with cardiotoxicity induced by epirubicin\/cyclophosphamide followed by docetaxel in patients with breast cancer","volume":"23","author":"Qin","year":"2018","journal-title":"Cancer Biomark"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e018143","DOI":"10.1161\/JAHA.120.018143","article-title":"Cardiotoxicity and cardiovascular biomarkers in patients with breast cancer:data from the GeparOcto-GBG 84 trial","volume":"9","author":"R\u00fcger","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3349\/ymj.2019.60.1.30","article-title":"Correlation of UGT2B7 polymorphism with cardiotoxicity in breast cancer patients undergoing epirubicin\/cyclophosphamide-docetaxel adjuvant chemotherapy","volume":"60","author":"Li","year":"2019","journal-title":"Yonsei Med J"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1200\/JCO.1995.13.11.2688","article-title":"Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer:high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study","volume":"13","author":"Gianni","year":"1995","journal-title":"J Clin Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e39170","DOI":"10.7759\/cureus.39170","article-title":"Capecitabine may accelerate atherosclerosis and causes acute myocardial infarction in the left main trunk","volume":"15","author":"Yamanaka","year":"2023","journal-title":"Cureus"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.5830\/CVJA-2012-074","article-title":"Acute arterial thrombosis following chemotherapy in a patient with a gastric carcinoma","volume":"24","author":"Doganci","year":"2013","journal-title":"Cardiovasc J Afr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00000421-200008000-00008","article-title":"Mesenteric venous thrombosis attributed to docetaxel","volume":"23","author":"Feenstra","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41420-025-02428-6","article-title":"The crosstalk of breast cancer and ischemic heart disease","volume":"11","author":"Luo","year":"2025","journal-title":"Cell Death Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1200\/JCO.2008.19.4274","article-title":"Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK national cancer research institute upper gastrointestinal clinical studies group","volume":"27","author":"Starling","year":"2009","journal-title":"J Clin Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"110709","DOI":"10.1016\/j.biopha.2020.110709","article-title":"microRNAs associated to anthracycline-induced cardiotoxicity in women with breast cancer:a systematic review and pathway analysis","volume":"131","author":"Pereira","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.21873\/anticanres.17551","article-title":"Cardioprotective effect of pegfilgrastim on chemotherapy-induced cardiotoxicity in preoperative chemotherapy for breast cancer","volume":"45","author":"Fujii","year":"2025","journal-title":"Anticancer Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/00001813-200008000-00007","article-title":"Use of docetaxel(taxotere)in patients with paclitaxel(taxol)hypersensitivity","volume":"11","author":"Moon","year":"2000","journal-title":"Anticancer Drugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1791074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:54:57Z","timestamp":1780030497000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1791074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":47,"alternative-id":["10.3389\/fcvm.2026.1791074"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1791074","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"article-number":"1791074"}}